Condition
Unresectable Biliary Tract Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Unresectable Biliary Tract Carcinoma clinical trials that are recruiting, at sites in 4 countries (most in South Korea (1), India (1), China (1)). By phase: Phase 2 (3), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Unresectable Biliary Tract Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Alternating chemo-immunotherapy and FGFR inhibitor for FGFR-positive biliary tract cancer | Phase 2 | Columbus, Ohio | Recruiting | Aug 24, 2026 |
| Trastuzumab plus chemotherapy versus chemotherapy alone for first-line HER2-positive advanced biliary tract cancer | Phase 3 | Muzaffarpur, Bihar and 5 other locations | Recruiting | Jul 14, 2025 |
| Combining Adebrelimab with Apatinib and Gemcitabine/Cisplatin for treating advanced Biliary Tract Carcinoma | Phase 2 | Zhengzhou | Recruiting | Dec 27, 2024 |
| Reducing severe neutropenia risk in patients with advanced pancreatic and bile duct cancers | Phase 2 | Goyang-si, Gyeonggi-do | Recruiting | Nov 18, 2023 |
All recruiting trials (4)
-
Alternating chemo-immunotherapy and FGFR inhibitor for FGFR-positive biliary tract cancer
This phase 2 trial tests whether alternating gemcitabine/cisplatin with durvalumab and the FGFR2 inhibitor pemigatinib can help people with unresectable or metastatic biliary tract cancers that have FGFR alterations.
-
Trastuzumab plus chemotherapy versus chemotherapy alone for first-line HER2-positive advanced biliary tract cancer
This trial will test if adding trastuzumab to standard first-line chemotherapy helps people with HER2-positive advanced or metastatic biliary tract cancer control their disease longer than chemotherapy alone.
-
Combining Adebrelimab with Apatinib and Gemcitabine/Cisplatin for treating advanced Biliary Tract Carcinoma
This study is testing a new combination of treatments for patients with advanced biliary tract cancer to see if it helps them more than standard chemotherapy alone.
-
Reducing severe neutropenia risk in patients with advanced pancreatic and bile duct cancers
This study is testing if a new medication can help people with advanced pancreatic and bile duct cancers avoid severe drops in their white blood cell count while they are getting chemotherapy.
Related topics
Quick answers
How many Unresectable Biliary Tract Carcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in South Korea (1 trial), India (1 trial), China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.